Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

HLA Heterozygosity Influences Colorectal Cancer Risk and Survival Outcome.

Journal article

Tsai Y-Y. et al, (2026), Gastroenterology, 170, 619 - 622

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Journal article

Cross WCH. et al, (2026), Cancer Discov, 16, 218 - 234

Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy.

Journal article

Matsubara Y. et al, (2026), Br J Cancer, 134, 463 - 468

Media coverage and PATHFINDER2: hype, simplification, and free advertising.

Journal article

Turnbull C. et al, (2026), Lancet Oncol, 27, 144 - 145

Load More